-
Mashup Score: 0
Johnson & Johnson MedTech (NYSE: JNJ) today announced the first completed commercial case with its Varipulse platform in Canada.
Source: www.massdevice.comCategories: General Medicine News, General HCPsTweet
Johnson & Johnson MedTech (NYSE: JNJ) today announced the first completed commercial case with its Varipulse platform in Canada.
Johnson & Johnson @JNJMedTech reports first commercial Varipulse use in #Canada | #PFA https://t.co/cEkUGWPmYD